Skip to main content

Albemarle Corporation (ALB)

Stock NYSE

$87.67

+1.03 (+1.17%)

Delayed quote.

Price history

Daily close
ALB daily closing price, Nov 18, 2025 to Nov 17, 2026 Closed at $121.39 on Nov 18, 2025 and $87.67 on Nov 17, 2026, a change of -27.78%. Range $87.67 to $215.62.
Daily closes, Nov 18, 2025 to Nov 17, 2026 (251 trading days).
Start
$121.39
Latest close
$87.67
Period change
-27.78%
Period low
$87.67
Period high
$215.62

Key metrics

Market cap
$10.53B
Volume
318.4K
Average volume
2.38M
52-week range
$87.27 – $221.00
Beta
1.36
Last dividend
$1.63
EPS (TTM)
$4.36
P/E ratio
20.11
Revenue (TTM)
$6.15B
Net income (TTM)
$681.63M
Total assets
$16.08B
Total debt
$1.88B
Cash and equivalents
$1.85B

Key financials (trailing twelve months).

Company profile

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Sector
Basic Materials
Industry
Chemicals - Specialty
Exchange
NYSE
CEO
Jerry Kent Jr.
Employees
7,800
Headquarters
Charlotte, NC, US
IPO date
1994-02-22

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$5.14B$5.38B$9.62B
Gross profit$671.62M$60.24M$1.20B
Operating income$93.79M-$636.01M$241.12M
EBITDA$558.00M-$294.13M$2.65B
Net income-$510.63M-$1.18B$1.57B
Diluted EPS-$5.75-$11.20$13.36
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$1.62B$1.19B$889.90M
Total assets$16.37B$16.61B$18.27B
Total liabilities$6.59B$6.41B$8.61B
Total debt$3.30B$3.62B$4.28B
Shareholders’ equity$9.53B$9.96B$9.41B
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow$1.28B$687.88M$1.33B
Capital expenditure-$589.80M-$1.68B-$2.15B
Free cash flow$692.47M-$992.65M-$827.96M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$1.55B$1.74B$1.43B$1.43B$1.31B$1.33B
Gross profit$300.72M$590.30M$500.97M$202.73M$117.61M$196.88M
Operating income$148.16M$452.94M$233.51M$48.25M-$30.46M$53.74M
EBITDA$329.43M$620.04M$445.12M-$22.94M$36.94M$287.96M
Net income$296.75M$479.96M$319.09M-$414.18M-$160.69M$22.90M
Diluted EPS$2.15$3.22$2.34-$3.87-$1.72-$0.16
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$1.85B$1.63B$1.09B$1.62B$1.93B$1.81B
Total assets$16.08B$15.91B$15.14B$16.37B$17.15B$17.29B
Total liabilities$5.26B$5.41B$5.03B$6.59B$6.88B$6.79B
Total debt$1.88B$1.99B$1.88B$3.30B$3.74B$3.72B
Shareholders’ equity$10.54B$10.28B$9.85B$9.53B$10.00B$10.24B
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow$405.80M$710.00M$346.24M$388.49M$355.60M-$7.20M
Capital expenditure-$80.37M-$71.73M-$98.68M-$155.38M-$132.16M-$119.63M
Free cash flow$325.42M$638.27M$247.57M$233.10M$223.44M-$126.83M